Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-07-12Clinical Trial Update: Near Infrared/ Ultrasound Dual Modal Imaging for Breast Cancer Diagnosis
The clinical trial evaluating near infrared and ultrasound dual-modal imaging for diagnosing breast cancer has completed.
-
CLINICAL_TRIALS research · 2007-07-11Clinical Trial Update: High Dose Chemotherapy and Autologous Transplant for Breast Cancer [Phase 2]
Phase 2 trial of high-dose chemotherapy with autologous stem cell transplant for breast cancer; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2007-07-06Clinical Trial Update: Paravertebral Block for Breast Surgery [Phase 4]
A Phase 4 clinical trial evaluating the use of a paravertebral block for breast cancer surgery has completed.
-
CLINICAL_TRIALS trial_result · 2007-06-29Clinical Trial Update: A Decision Aid for Women With Early Stage Breast Cancer [Phase 3]
This report covers a Phase 3 clinical trial of a decision aid designed to help women with early-stage breast cancer make informed treatment …
-
CLINICAL_TRIALS trial_result · 2007-06-27Clinical Trial Update: The Use of Silver Leaf Dressing in the Prevention of Radiotherapy Induced Skin Reactions [Phase 3]
A Phase 3 trial evaluating the use of Silver Leaf Dressing to prevent radiotherapy-induced skin reactions in breast cancer patients has comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2007-06-26Clinical Trial Update: A Prospective, Single-Arm Study to Evaluate the Efficacy and Safety of Zoladex 3.6mg Combined With CEF Chemotherapy as Neo-Adjuvant Therapy in Hormone Responsive, Premenopausal, Operable Breast Cancer [NA]
This clinical trial update describes a prospective, single-arm study evaluating the efficacy and safety of Zoladex 3.6 mg combined with CEF …
-
CLINICAL_TRIALS trial_result · 2007-06-22Clinical Trial Update: Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating pemetrexed as first-line chemotherapy for advanced breast cancer. The study is completed.
-
CLINICAL_TRIALS trial_result · 2007-06-21Clinical Trial Update: Tamoxifen-MRI Study [Phase 2]
Phase 2 trial of tamoxifen with MRI for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2007-05-28Clinical Trial Update: Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents [Phase 3]
Phase III trial in breast cancer comparing gemcitabine plus a cytotoxic agent to two cytotoxic agents has completed; sponsor is Eli Lilly.
-
CLINICAL_TRIALS trial_result · 2007-05-25Clinical Trial Update: A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment [Phase 4]
This Phase 4 study of arzoxifene (LY353381) completed, evaluating continuation of treatment in patients who had previously benefited. The st…
-
CLINICAL_TRIALS trial_result · 2007-05-21Clinical Trial Update: Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer [Phase 3]
A Phase 3 breast cancer trial comparing docetaxel followed by CEF versus docetaxel with capecitabine followed by CEX as adjuvant therapy; th…
-
CLINICAL_TRIALS research · 2007-05-16Clinical Trial Update: Radiation Induced Atherosclerosis in Breast Cancer Patients
This clinical trial is studying radiation-induced atherosclerosis in breast cancer patients. The current status of the study is unknown.
-
CLINICAL_TRIALS trial_result · 2007-05-15Clinical Trial Update: Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating motexafin gadolinium in combination with docetaxel for patients with advanced solid tumors; the study, including br…
-
CLINICAL_TRIALS trial_result · 2007-05-04Clinical Trial Update: A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer [Phase 2]
A Phase II trial evaluating CI-1033 for metastatic breast cancer has completed. The update notes the trial status but does not include resul…
-
CLINICAL_TRIALS trial_result · 2007-05-04Clinical Trial Update: A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer [Phase 2]
Pfizer conducted a multicenter Phase 2 trial of CI-1040 in patients with advanced colorectal cancer, breast cancer, non-small cell lung canc…
-
FDA approval · 2007-04-27FDA Approved: TYKERB — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tykerb (lapatinib) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2007-04-26FDA Approved: FLUOROURACIL — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare’s original application for Fluorouracil as a generic injectable chemotherapy agent for multiple cancers.
-
CLINICAL_TRIALS trial_result · 2007-04-20Clinical Trial Update: Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma [Phase 2]
Phase II trial of capecitabine with weekly docetaxel followed by capecitabine maintenance for metastatic breast cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2007-04-19Clinical Trial Update: Complementary Therapies for the Reduction of Side Effects During Chemotherapy for Breast Cancer [Phase 4]
A Phase 4 clinical trial evaluating complementary therapies to reduce chemotherapy-related side effects in breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2007-04-17Clinical Trial Update: Wellbutrin XL, Major Depressive Disorder and Breast Cancer [Phase 4]
A Phase 4 clinical trial update reports the completion of a study evaluating Wellbutrin XL (bupropion) for major depressive disorder in pati…
-
FDA approval · 2007-04-11FDA Approved: FEMARA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Femara (letrozole) from Novartis Pharmaceuticals Corporation, updating the existing NDA.
-
CLINICAL_TRIALS research · 2007-04-04Clinical Trial Update: Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery [Phase 2]
A Phase 2 clinical trial evaluating a triple-drug regimen of docetaxel, carboplatin, and capecitabine before surgery for locally advanced or…
-
CLINICAL_TRIALS trial_result · 2007-03-22Clinical Trial Update: Gemcitabine + Carboplatin in Breast Cancer [Phase 2]
Phase 2 study evaluating the combination of gemcitabine and carboplatin in breast cancer has completed; the snippet notes completion but doe…
-
FDA approval · 2007-03-13FDA Approved: TYKERB — Original Application (Novartis Pharmaceuticals Corporation)
FDA's Original Application page documents the original FDA approval of TYKERB (lapatinib) for HER2-overexpressing breast cancer.
-
CLINICAL_TRIALS trial_result · 2007-03-12Clinical Trial Update: Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy [Phase 4]
Phase 4 clinical trial assessing whether ketamine (Ketalar) given perioperatively can prevent chronic postoperative pain after mastectomy. T…